Back

Cost analysis of microaxial flow pump (Impella) versus standard care in cardiogenic shock: findings from the danger shock trial

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Optimising cardiovascular systems: access, innovation, and socioeconomic determinants of outcomes Health Economics ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Britt Borregaard

Odense University Hospital, Odense (Denmark)

5 More presentations in this session

Presentation thumbnail
The impact of cardiac implantable electronic devices on delays to acute magnetic resonance imaging: a two-year service evaluation
Doctor M. Dosanj (Coventry, GB)
Abstract
Presentation thumbnail
Financial strain among U.S. adults with cardiovascular conditions following reductions in food assistance benefits: a quasi-experimental policy analysis
Doctor P. Narasimmaraj (Boston, US)
Abstract
Presentation thumbnail
Effectiveness of a bivalent RSV prefusion F protein-based vaccine in individuals with and without atherosclerotic cardiovascular disease: a prespecified analysis of the DAN-RSV trial
Doctor M. Pareek (Copenhagen, DK)
Abstract
Presentation thumbnail
Building a national real-time cardiovascular quality infrastructure: five years of ESC EuroHeart implementation in Estonia
Doctor M. Serg (Tallinn, EE)
Abstract
Presentation thumbnail
Associations of socioeconomic status with length of hospital stay in a recent german myocardial infarction registry
Doctor D. Fueller (Brandenburg an der Havel, DE)
Abstract

Access the full session

Session thumbnail
Optimising cardiovascular systems: access, innovation, and socioeconomic determinants of outcomes

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Real-world outcomes of microaxial flow pump use in cardiogenic shock: comparison with the DanGer Shock cohort
20 March 2026
thumbnail
Congress Presentation
Budget impact of a personalized follow up in a heart failure unit based on a new model of risk stratification.
22 May 2023
thumbnail
Congress Presentation
Budget impact analysis of antiplatelet therapy with cangrelor in patients with acute coronary artery disease undergoing percutaneous coronary intervention in Belgium
13 March 2021
thumbnail
Congress Presentation
Economic evaluation of Impella versus VA-ECMO in acute myocardial infarction cardiogenic shock
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources